Osstem Implant, the number one bidder for the Chinese government ... "The strategy to maximize sales worked."

Reporter Kim Jisun / approved : 2023-01-12 02:45:33
  • -
  • +
  • 인쇄
This article is translated by AI company Flitto and Newsroom neural machine translation technology

 

Osstem Implant announced on the 11th that it won the bid for 491,090 sets, the largest amount among the participating companies, in the Chinese government's first bid for volume-based procurement (VBP) for dental implants. 

 

The company explains that this is 2.3 times the amount that Straumann, the world's No. 1 implant company, won the bid.


VBP is a policy in which the government lowers prices by directly making large-scale purchases according to the results of a pre-demand survey to increase patient access to medicines and medical devices. China introduced the VBP policy for dental implants for the first time this year. They said that if implants were included in the VBP list, supply prices would fall, which would hurt domestic companies operating in China, but the results were the opposite.

In a demand survey of local dental clinics conducted by the Chinese government earlier, 47 percent, nearly half of those surveyed, said they would purchase Osstem implant products, the company explained. Osstem Implant plans to strengthen its promotion and operations in China, believing that if the price of implant procedures falls due to the implementation of VBP, demand will increase.

Alphabiz Reporter Kim Jisun(stockmk2020@alphabiz.co.kr)

주요기사

[Exclusive] Samsung Electronics Passes NVIDIA’s HBM3E 12-High Qualification Test, Secures Supply Deal2025.09.19
Civic Groups File Complaint Against Baemin and Coupang Eats Over Alleged Misleading “One-Person Free Delivery” Promotions2025.09.19
KT Confirms Additional Victims in Unauthorized Micro-Payment Case, Faces Criticism Over Initial Response2025.09.19
KFTC Grants Conditional Approval for Joint Venture Between Shinsegae Group and Alibaba Group2025.09.19
Supreme Court Rules in Favor of NTS on U.S. Unregistered Patent Royalties2025.09.19
뉴스댓글 >

건강이 보이는 대표 K Medical 뉴스

HEADLINE

PHOTO

많이 본 기사